CXCL13/CXCR5 axis facilitates endothelial progenitor cell homing and angiogenesis during rheumatoid arthritis progression.
Chun-Hao TsaiChao-Ju ChenChi-Li GongShan-Chi LiuPo-Chun ChenChien-Chung HuangSung-Lin HuShih-Wei Wang LChih-Hsin TangPublished in: Cell death & disease (2021)
Angiogenesis is a critical process in the formation of new capillaries and a key participant in rheumatoid arthritis (RA) pathogenesis. The chemokine (C-X-C motif) ligand 13 (CXCL13) plays important roles in several cellular functions such as infiltration, migration, and motility. We report significantly higher levels of CXCL13 expression in collagen-induced arthritis (CIA) mice compared with controls and also in synovial fluid from RA patients compared with human osteoarthritis (OA) samples. RA synovial fluid increased endothelial progenitor cell (EPC) homing and angiogenesis, which was blocked by the CXCL13 antibody. By interacting with the CXCR5 receptor, CXCL13 facilitated vascular endothelial growth factor (VEGF) expression and angiogenesis in EPC through the PLC, MEK, and AP-1 signaling pathways. Importantly, infection with CXCL13 short hairpin RNA (shRNA) mitigated EPC homing and angiogenesis, articular swelling, and cartilage erosion in ankle joints of mice with CIA. CXCL13 is therefore a novel therapeutic target for RA.
Keyphrases
- vascular endothelial growth factor
- endothelial cells
- rheumatoid arthritis
- high glucose
- disease activity
- ankylosing spondylitis
- poor prognosis
- end stage renal disease
- interstitial lung disease
- wound healing
- newly diagnosed
- signaling pathway
- systemic lupus erythematosus
- ejection fraction
- high fat diet induced
- knee osteoarthritis
- pi k akt
- chronic kidney disease
- transcription factor
- binding protein
- staphylococcus aureus
- peritoneal dialysis
- pseudomonas aeruginosa
- cell proliferation
- epithelial mesenchymal transition
- endoplasmic reticulum stress